ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/16/2023
Back to search
Official data from USPTO
NUCLERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NUCLERA
ST13
US500000079294807Class
1, 5, 9, 10, 40, 42, 44
Filing
79294807
Registration
6624194
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/16/2023
Trademark type
Word
Nice classes
1, 5, 9, 10, 40, 42, 44
Filing date
11/19/2019
Registration date
01/25/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CHHINA, KARANENDRA S
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nuclera Ltd
Nuclera Nucleics Ltd
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for scientific purposes; chemicals for use in research; chemicalsenzymesDNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological and biochemical reagents; gene editing enzymes
Class 5
Biologicalchemical and biochemical reagentsDNA and RNA productsproteins and gene editing enzymes for clinical or medical laboratory use; pharmaceutical and veterinary preparationsnucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; therapeutic DNA and RNAnucleic acid sequences and chemical reagents for medical and veterinary purposes
Class 9
Scientific research and laboratory apparatusscientific desktop instruments for geneRNA and protein synthesis; semiconductorssemiconductor chipsmicrochipsbio-sensorsbio-chips; scientific research and laboratory apparatusapparatus for amplifying DNA and RNAapparatus for manufacturing DNA and RNAapparatus for processing DNA and RNA; apparatus for recordingtransmission or reproduction of data including videoaudioimages and text for scientific purposes; data processing equipment and computers; computer hardware; downloadable and recorded computer software for scientific data analysis; downloadable and recorded computer programs for scientific data analysis; data carriers containing scientific data; parts and fittings for all the aforesaid goods
Class 10
Medical and veterinary apparatus and instruments namelyapparatus for DNA and RNA analysissequencing and synthesis; apparatus for geneRNA and protein synthesis for medical and veterinary purposes
Class 40
Custom manufacture of therapeutic drugsincluding therapeutic DNARNAgenes and oligonucleotides; manufacture of synthetic DNARNAgenes and oligonucleotides for others
Class 42
Scientific and technological servicesscientific researchstructural and functional analysis of genomes and genetic testing and in the fields of genomicsDNA and RNA sequencinggene synthesisRNA synthesisprotein synthesisgene identificationgene cloninggene expressiongene mappingresearch and design in the field of DNA research and developmentgene and protein synthesis; chemical and biological analysis and research services; research into DNA and RNA for scientific purposes; research and development into the creation of DNA and RNA; researchdevelopmentscientific testing and analysis in the field of genomicsDNA and RNA sequencinggene synthesisgene identificationgene cloninggene expressiongene mapping; scientific research in the field of molecular biologynext generation sequencinghigh-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating libraries or collections of normal and mutated genes for scientific research purposes; electronic data storage services; consultancy and advisory services relating to the aforesaid services
Class 44
Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testingsequencing and measuring services for medical and health purposes; provision of information relating to the analysis of DNA and RNA for medical and health purposes; providing advice and consultancy in the field of medical and veterinary therapies
Publications
History of USPTO decisions and trademark events.
31 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/25/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/30/2022
FIMP
FINAL DISPOSITION PROCESSED
06/29/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
12/17/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
12/16/2021
APET
ASSIGNED TO PETITION STAFF
12/16/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/01/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/29/2021
RFNT
REFUSAL PROCESSED BY IB
11/22/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/03/2020
RFRR
REFUSAL PROCESSED BY MPU
11/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/09/2020
CNRT
NON-FINAL ACTION WRITTEN
10/08/2020
DOCK
ASSIGNED TO EXAMINER
10/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens NUCLERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.